John Dobak, Chief Executive Officer at DermTech, Inc. (DMTK), sold 49,079 shares at $46.79 ($2.3M) on 2021-04-12, disclosed to the SEC on 2021-04-14.
Open-market sale of $2.3M DMTK by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.94 | 14,343 | $659K | 29.0% |
| 2 | $45.94 | 14,343 | $659K | 29.0% |
| 3 | $46.79 | 9,736 | $456K | 20.0% |
| 4 | $46.79 | 9,736 | $456K | 20.0% |
| 5 | $47.90 | 921 | $44K | 1.9% |
| Total | $46.31 avg | 49,079 |
| $2.3M |
| 100% |
| Filing → |
| DMTK | SELL | 2022-03-15 | $19K | — | Filing → |
| DMTK | SELL | 2022-03-09 | $43K | — | Filing → |
| DMTK | SELL | 2021-12-16 | $33K | — | Filing → |